Innocon Medical

InnoCon Medical’s UCon System is a patented neuromodulation approach designed to address symptoms of overactive bladder and bowel dysfunction. Unlike currently available neuromodulation therapies, UCon targets the dorsal genital nerve (DGN). Targeting DGN offers a unique opportunity for on-demand (urge) stimulation. On-demand stimulation mode lets patients activate therapy precisely when the urge hits, ideally giving them more control and time to reach a toilet. The system offers two electrode options: Patch Electrode: a non-invasive, replaceable option suitable for daily use and initial screening. Bar Electrode: a long-term, partially implantable alternative, designed for permanent placement but removable when needed, e.g, for MRI scans. UCon is being developed to provide patients and healthcare systems a more cost-effective and therefore accessible alternative compared to other sacral and tibial implantable neuromodulation systems. To learn more, visit: innoconmedical.com CAUTION: The UCon System is currently under clinical investigation and limited by law to investigational use only- Privacy statement: By visiting and interacting with this company page, LinkedIn will process your personal data as described in the Joint Controller Addendum (https://legal.linkedin.com/pages-joint-controller-addendum) and in the Privacy Policy InnoCon Medical uses the data of visitors on this page for marketing purposes. InnoCon Medical jointly controls personal data with LinkedIn. InnoCon Medical contact details: Address: Lyngvej 1, Aalborg CVR: 38635794 Telephone:+45 9398 7033 Email: contact@innoconmedical.dk Website: Contact person: Jesper Nielsen, CEO